https://www.telegraph.co.uk/food-and-drink/features/drinking-vinegar-could-secret-midlife-weight-loss/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243436/
If you eat a high carb diet, it's likely your body is too akaline. Do you have acid reflux? Then ACV may be the solution.
From the NIH studies:
Overall, nine studies, including 10 study arms, were included in this meta-analysis. We found that ACV consumption significantly decreased serum total cholesterol (− 6.06 mg/dL; 95% CI: − 10.95, − 1.17; I2: 39%), fasting plasma glucose (− 7.97 mg/dL; 95% CI: − 13.74, − 2.21; I2: 75%), and HbA1C concentrations (− 0.50; 95% CI: − 0.90, − 0.09; I2: 91%). No significant effect of ACV consumption was found on serum LDL-C, HDL-C, fasting insulin concentrations, or HOMA-IR. The stratified analysis revealed a significant reduction of serum TC and TG in a subgroup of patients with type 2 diabetes, those who took ≤15 mL/day of ACV, and those who consumed ACV for > 8-weeks, respectively. Furthermore, ACV consumption significantly decreased FPG levels in a subgroup of studies that administered ACV for > 8-weeks. Further, ACV intake appeared to elicit an increase in FPG and HDL-C concentrations in apparently healthy participants.
Furthermore, Acetic Acid in ACV inhibits the liver's ability to produce glucose and activates the AMPK pathway. AMPK is one of the pathways to longevity:
https://pubmed.ncbi.nlm.nih.gov/16630552/
https://www.telegraph.co.uk/food-and-drink/features/drinking-vinegar-could-secret-midlife-weight-loss/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243436/
If you eat a high carb diet, it's likely your body is too akaline. Do you have acid reflux? Then ACV may be the solution.
From the NIH studies:
*Overall, nine studies, including 10 study arms, were included in this meta-analysis. We found that ACV consumption significantly decreased serum total cholesterol (− 6.06 mg/dL; 95% CI: − 10.95, − 1.17; I2: 39%), fasting plasma glucose (− 7.97 mg/dL; 95% CI: − 13.74, − 2.21; I2: 75%), and HbA1C concentrations (− 0.50; 95% CI: − 0.90, − 0.09; I2: 91%). No significant effect of ACV consumption was found on serum LDL-C, HDL-C, fasting insulin concentrations, or HOMA-IR. The stratified analysis revealed a significant reduction of serum TC and TG in a subgroup of patients with type 2 diabetes, those who took ≤15 mL/day of ACV, and those who consumed ACV for > 8-weeks, respectively. Furthermore, ACV consumption significantly decreased FPG levels in a subgroup of studies that administered ACV for > 8-weeks. Further, ACV intake appeared to elicit an increase in FPG and HDL-C concentrations in apparently healthy participants.*
Furthermore, Acetic Acid in ACV inhibits the liver's ability to produce glucose and activates the AMPK pathway. AMPK is one of the pathways to longevity:
https://pubmed.ncbi.nlm.nih.gov/16630552/
(post is archived)